Back to Search
DR. RAYMOND THERTULIEN M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1275759581IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
2007-00361(NC)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
2007-00361(NC)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
2007-00361(NC)
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1994
Research & Publications (15)
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
PMID 17895401·Blood·2008
8-other
RE 10104: Abou-Jawde et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma. Haematologica 2006; 91: 1410-1413.
PMID 17405758·Haematologica·2007
8-other
Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
PMID 16525139·N Engl J Med·2006
3-trial
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation.
PMID 16435020·Bone Marrow Transplant·2006
8-other
Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients.
PMID 16532017·Bone Marrow Transplant·2006
2-rct
Health care policy issues as a result of the genetic revolution: implications for public health.
PMID 15727963·Am J Public Health·2005
6-review
Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
PMID 14767499·Bone Marrow Transplant·2004
8-other
Deep septic thrombophlebitis: an unrecognized cause of relapsing bacteremia in patients with cancer.
PMID 15084634·J Clin Oncol·2004
8-other
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
PMID 15327525·Br J Haematol·2004
3-trial
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning.
PMID 12543109·Exp Hematol·2003
4-observational
Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience.
PMID 14617011·Br J Haematol·2003
8-other
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.
PMID 12837152·Clin Lymphoma·2003
8-other
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
PMID 12476279·Bone Marrow Transplant·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via ASHEVILLE HEMATOLOGY & ONCOLOGY ASSOCIATES PA · 5 locations total
- Address
- 20 MEDICAL PARK DR
ASHEVILLE, NC 28803 - Phone
- (828) 254-8232
Locations (5)
ASHEVILLE HEMATOLOGY & ONCOLOGY ASSOCIATES PA
20 MEDICAL PARK DR, ASHEVILLE, NC
(828) 254-8232
Practice Location
125 QUEENS RD STE 610, CHARLOTTE, NC
(980) 302-6600
Practice Location
600 HOSPITAL DR STE 10B, CLYDE, NC
(828) 456-5214
Practice Location
50 HOSPITAL DR STE 4B, HENDERSONVILLE, NC
(828) 681-2917
Practice Location
179 N BUNCOMBE SCHOOL RD STE 102, WEAVERVILLE, NC
(828) 645-3100
Quick Facts
- NPI
- 1275759581
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 5
- Years in Practice
- 32
- Publications
- 15
Are you this provider?
Claim Your Profile